Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: A Study of CM310 in Subjects With Moderate to Severe Asthma [Phase 2, Phase 3]
Clinical trial update for CM310 in moderate to severe asthma (Phase 2/Phase 3) indicating ongoing recruitment.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. [Phase 4]
Phase 4 trial comparing Respimat inhaler to a hydrochlorofluorocarbon metered-dose inhaler (HFA MDI) using Berodual in COPD patients with po…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® [Phase 3]
Phase 3 trial comparing budesonide/formoterol SPIROMAX inhalation powder to Symbicort Turbohaler in asthma; results posted after completion.
-
FDA approval · 2023-12-05FDA Approved: PREDNISONE TABLETS, USP, 5 MG — Supplemental Application (Granulation Technology, Inc.)
FDA granted a supplemental approval for Prednisone Tablets, USP, 5 mg to authorize a granulation technology manufacturing change by Granulat…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Poly-unsaturated Fats for Improving Nasal Polyps and Asthma [Phase 3]
Phase 3 clinical trial exploring poly-unsaturated fats for improving nasal polyps and asthma is underway with status unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Comparison of Biologicals in Treatment of Severe Asthma
Completed clinical trial comparing biological treatments for severe asthma with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 clinical trial comparing flow rate effects of the Respimat inhaler versus a metered-dose inhaler using Berodual in COPD and asthma p…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma. [Phase 3]
A phase 3 trial comparing Foster 100/6 mg NEXThaler with Foster 100/6 mg pMDI in adults with controlled asthma has completed.
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, representing an additional approva…
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA, enabling a supplemental …
-
FDA approval · 2023-11-27FDA Approved: ZAFIRLUKAST — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for Zafirlukast from Aurobindo Pharma Limited, providing a generic option for asthma.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Cross-sectional Study to Measure Cough in Severe Asthma [NA]
A completed cross-sectional study investigating cough in individuals with severe asthma; results have been posted.
-
FDA approval · 2023-11-21FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s Montelukast Sodium supplemental application for the generic product, enabling its labeling and market …
-
CLINICAL_TRIALS research · 2023-11-18Clinical Trial Update: Intervention for Depressed Latina Mothers of Children With Asthma [Phase 2]
Phase 2 clinical trial update evaluating an intervention for depressed Latina mothers of children with asthma.
-
FDA approval · 2023-11-16FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental NDA for Fluticasone propionate and salmeterol, expanding its labeling and approved uses.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus® [Phase 3]
Phase 3 trial comparing single-dose Fluticasone/Salmeterol 500/50 μg delivered by Elpenhaler vs Diskus in asthma; study completed.
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Study of ARRY-502 in Patients With Persistent Asthma [Phase 2]
Phase 2 study of ARRY-502 in persistent asthma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Mechanism(s) of Airflow Limitation During Exacerbation of Asthma [Phase 4]
Phase 4 clinical trial updating on mechanisms of airflow limitation during asthma exacerbations.
-
FDA approval · 2023-10-24FDA Approved: THEOPHYLLINE — Original Application (Harman Finochem Limited)
FDA approved Harman Finochem Limited's original application for Theophylline, enabling its generic manufacture and marketing under an ANDA O…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: RVA Breathes: A Richmond City Collaboration to Reduce Pediatric Asthma Disparities [NA]
Clinical trial update for RVA Breathes investigating pediatric asthma disparities; study completed with results posted.
-
FDA approval · 2023-10-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.
-
FDA approval · 2023-09-21FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., authorizing a supplemental action related to a…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: TNF-alpha Directed Therapy in Asthma [Phase 2]
Phase 2 clinical trial update evaluating TNF-alpha directed therapy in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids [Phase 2, Phase 3]
Phase 2/3 trial evaluating nutrigenetic response to omega-3 fatty acids in individuals with obesity and asthma; study completed with results…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Biologics and Sublingual Immunotherapy [Phase 4]
Phase 4 clinical trial update on biologics and sublingual immunotherapy for allergic asthma conditions; not yet recruiting.